학술논문
The beneficial effects of Xolair® (Omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV - The Israeli arm of the INNOVATE study
Document Type
Article
Author
Source
In: Israel Medical Association Journal . (Israel Medical Association Journal, June 2007, 9(6):472-475)
Subject
Language
English
ISSN
15651088